SEC Filing Summary: Ventrus Biosciences, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Ventrus Biosciences, Inc. on May 16, 2012. The registrant is incorporated in Delaware and maintains its principal executive offices in New York, New York. The filing serves as a current report to disclose a specific corporate event rather than a periodic financial report.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to attach a presentation and does not contain audited or unaudited financial statements.
Material Changes
There are no material changes to financial performance or operations reported in this specific filing. The document solely announces the presentation of a PowerPoint deck at an external conference.
Guidance, Outlook, and Management Commentary
Item 8.01 (Other Events): The company disclosed that it will present a PowerPoint presentation at the Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas, Nevada, on May 16, 2012, at 3:40 pm Pacific Time. This presentation is attached as Exhibit 99.1 and incorporated by reference. The filing itself contains no specific guidance, risk factors, or management commentary beyond the announcement of this event.
Key Facts for Investor Verification
- Verify the content of the attached Exhibit 99.1 (PowerPoint presentation) for actual business updates, as the 8-K text only references the event.
- Confirm the company name is Ventrus Biosciences, Inc. (Note: The request metadata mentioned "Assembly Biosciences," but the filing explicitly identifies Ventrus Biosciences).
- Check the date of the conference presentation: May 16, 2012.
- Review the filing for any subsequent updates regarding the company's financial status, as this 8-K contains no financial data.